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Namita Seth Mohta, MD, interviews George Diaz, MD, Medical Director, Antimicrobial Stewardship; Infectious Disease Hospitalist; and Section Chief, Infectious Diseases at Providence Regional Medical Center Everett.

Namita Seth Mohta:

This is Namita Seth Mohta for NEJM Catalyst. I am speaking today with Dr. George Diaz, part of the leadership team at the Providence St. Joseph Health System in Washington, who is helping to lead the response to the Covid-19 pandemic.

Dr. Diaz and I will talk today about his experience with the Covid-19 pandemic. Our objective is to discuss care delivery --- the very mission of NEJM Catalyst --- during a unique and defining moment. Thank you for joining us today.

George Diaz:

Thanks for having me.

Mohta:

Share with us some background. Tell us a little bit about Providence St. Joseph as a system, how it's organized, and how it provides care for patients.

Diaz:

Providence Saint Joseph Health has 51 hospitals, primarily on the West Coast including Alaska, Washington, Montana, Oregon, California, New Mexico, and Texas. We have about 1,000 clinics. It has a central structure for clinical governance. Each of the specialties within the clinical arena has engaged providers that provide decision-making for the health system. Along those lines, we have a unified EMR \[electronic medical record\]. We are on the Epic platform and infectious diseases content is one of the areas that I work in to build into our EMR.

"We received the first patient in the U.S. with coronavirus in January, and as soon as the first patient arrived to our hospital, we activated our Special Pathogens Unit and employed our dedicated volunteer staff of nurses and other staff who work with special pathogens."

The hospital where I practice infectious diseases is in Everett, Washington, just north of Seattle. We are a 600-bed hospital, the largest hospital in our county, which is one of the areas hardest hit with the current pandemic. We received the first patient in the U.S. with coronavirus in January,[@r1] and as soon as the first patient arrived to our hospital, we activated our Special Pathogens Unit and employed our dedicated volunteer staff of nurses and other staff who work with special pathogens.

On arrival of the first patients, I begin coordinating closely with our system leadership to begin a centralized response to what was likely going to be additional patients coming to our health system. Within 24 hours of the first patient arriving, we updated our electronic medical record to begin screening patients for possible coronavirus infection based on travel history, and by 5 p.m. the next day, all of our hospitals, ERs, urgent care clinics, outpatient clinics, any other ancillary clinics, were all screening patients looking for possible additional patients who could be Covid-positive based on their epidemiological risk.

Mohta:

Let me clarify that I heard correctly that within 24 hours you had a template up in the EMR, and within what sounds like 1 to 2 days pretty much every part of the hospital was up and functioning in terms of being able to screen patients. How did you implement so quickly?

Diaz:

We have a leadership group led by Dr. Amy Compton-Phillips[@r2] who made a decision the night we had a patient arrive that we needed to be prepared for any patient presenting anywhere in our organization. We already have the framework within our EMR to rapidly upload different contagions for screening. We had done this for things like [Ebola](https://www.cdc.gov/vhf/ebola/index.html), [MERS](https://www.cdc.gov/coronavirus/mers/index.html), [SARS](https://www.cdc.gov/sars/index.html), etc. The tool that we designed ourselves within Epic allows us to turn on screening at the county level, where outbreaks are often determined.

"Because this appeared to be a threat that would not be limited to a single county, the senior leadership team within our health system provided guidance to our clinical leadership to implement the screening immediately."

In this particular case, because this appeared to be a threat that would not be limited to a single county, the senior leadership team within our health system provided guidance to our clinical leadership to implement the screening immediately. The build team begin working essentially overnight to update the EMR to allow for screening across our entire enterprise.

Mohta:

And then what happened?

Diaz:

At that point, we did end up caring for the patient locally. One of the things we noticed was that our team that was prepared to receive a patient with, for example, Ebola, was limited to about 15 nurses. We knew, given what we saw in China, that the volume of patients coming into our health system potentially could grow exponentially. We began operational plans to increase the number of staff within our hospital to be able to have large numbers of nursing staff be adept at managing patients with potentially highly communicable diseases. This not only improved our hospital, but simultaneously occurred across our health system through centralized governance that provided the same work and operational plan for readying staff for taking care of these patients system wide.

With our hospital, we also began implementing plans for surge capacity. Thankfully for my hospital, one entire floor was built in a way that could accommodate the entire floor to be on negative air pressure. That particular unit has 64 beds. We made plans for being able to cohort all our patients who were Covid-positive and Covid rule-outs initially on that floor, so that we would have the nursing expertise localized to one part of the hospital at least early on.

The other thing that we had to consider was how we are going to manage volume. We began developing algorithms within our health system to triage patients, either for admission or for home; since we knew based on literature coming out of China that there were a substantial number of patients who developed complications from Covid later in their illness, we felt it was important to design a system that could detect changes in the patient's status if they happen to be discharged from the ED.

"This not only improved our hospital, but simultaneously occurred across our health system through centralized governance that provided the same work and operational plan for readying staff for taking care of these patients system wide."

We also knew that \[personal protective equipment\] PPE would be potentially limited and so we wanted to devise a way to minimize the use of PPE as much as possible while keeping patients safe. The solution we came up with was to deploy our telehealth system in a way to be able to safely monitor both Covid-positive patients and ED-discharge patients to home using our telehealth system. We modified the EMR in a way that patients could enter data themselves into MyChart --- it's their record --- including templates for the telehealth system to enter notes into EMR so that anybody accessing the patient record would have access to the telehealth notes as well.

We developed workflows for a warm handoff between both ED discharges to home as well as inpatient-to-home discharges, where the discharging nurse did a warm handoff to telehealth nursing.

So far, we have in the range of about 200 patients within our system right now being actively monitored from home. The number of patients returning to the hospital has been relatively small, on the order of less than 10.

Mohta:

Let me ask a couple of follow-up questions in this part of the journey. The first is where are we in time now? The first patient came in, in January, and now you're describing algorithms and elegant workflows around warm handoffs and integrating telemedicine and telehealth; that's one question. The second is, in this time period, how are you managing testing? Because a lot of what you're talking to me about is dependent on whether the patient is Covid-positive or not. The third is, if you could talk a little bit --- in these transitions between ED to home, or inpatient to home --- about the algorithms that you use to decide whether somebody was safe to go home, or not. That is a big unknown.

Diaz:

I'll answer the last one first, the question about how you decide to send someone home from ED or inpatient. We currently have clinical trials that give us entry criteria for at least what's defined as severe pneumonia by inclusion criteria to the clinical trial, and we essentially use those as a way to determine if someone should be either actively monitored or admitted to the hospital.

"So far, we have in the range of about 200 patients within our system right now being actively monitored from home. The number of patients returning to the hospital has been relatively small, on the order of less than 10."

An example would be that the current trial looks at oxygen saturation. If it's below 94%, for the most part those folks will meet entry for clinical trial, and if those patients are close to requiring oxygen or have another reason for admission, the ED docs will then admit them to the hospital for admission.

If patients then stabilize, and oxygen levels improve in the hospital, then they can be discharged to telehealth from the inpatient setting. We are primarily using oxidation status as the way that we determine if someone can safely go home from both ED and hospital.

For the second question, system. I would say it was roughly 6 weeks from the time the first patient walked in the door to the time that we were employing this alternative \[telehealth\] care model.

Mohta:

Because many of these algorithms appropriately depend on whether a patient is Covid-positive or negative, how did you handle the scarcity of testing kits during this time frame?

Diaz:

That's a great question. One of the reasons we also thought that we could use telehealth monitoring was because early on when we started to see a surge in volumes, we did not have rapid access to testing and it took as long as 4 or 5 days to get a result. We were discharging in large numbers people under investigation rather than people who were Covid-positive. Once results came back from testing and they were outpatients, as long as they were clinically stable and if they were Covid-negative they would be then discharged from telehealth. If they were Covid-positive after discharge from the ED or inpatient, then they would continue to be monitored until near resolution of symptoms.

The lack of testing, it was a big problem, but we mitigated it by being able to discharge many of these folks outside the hospital setting.

"What we're learning now is that in areas where we have populations that are growing and perhaps we don't have the number of beds that will need to be built to support the increases in population, that we're going to need to rely on telehealth models to be able to provide care."

Mohta:

And then monitoring them via telehealth.

Diaz:

Exactly. They would get hooked up with the telenurse and they would download Zoom at home, or if they were an elderly person who didn't have access to a computer, all the monitoring could be done by phone.

Mohta:

Given your experiences over the last few months, what will health care delivery look like in the future? How will it be different than what we knew pre-Covid-19?

Diaz:

What we're learning now is that in areas where we have populations that are growing and perhaps we don't have the number of beds that will need to be built to support the increases in population, that we're going to need to rely on telehealth models to be able to provide care. It may be people who are local can stay home; there certainly are large numbers of people who have difficulty leaving their homes and going to a clinic. Those patients could definitely benefit from telehealth services. Likewise, patients who live a little bit farther away from the hospital, in rural areas where it's a burden to drive long-distance just to get care, the virtual visits will be a great way to expand care without expanding brick-and-mortar facilities.

Mohta:

What are some of the challenges that you've had with implementing and now sustaining and scaling this model as you're using telehealth to manage the pandemic? And what are some challenges you see, either same or different, in the future, post-Covid?

Diaz:

I would say that the largest management issue is finding and being able to scale qualified staff for rapid-scale increases in telehealth volumes. If the health system has time and a plan, they can scale their staff appropriately, but scaling it rapidly as we've done requires identification of the resources to create a program like this that can scale into a multistate scenario.

The other area that has been difficult has been cross-state licensing. Currently we've had difficulty in being able to contract nurses in the state where they reside, and where the patients live, if that particular state does not have cross-state agreements on credentialing.

"The biggest success story I would say is that using our telehealth model, so far we've been successful in having patients be in the right place for the type of care they require."

Mohta:

To end on a positive note, share with us a success story from these last few weeks.

Diaz:

The biggest success story I would say is that using our telehealth model, so far we've been successful in having patients be in the right place for the type of care they require. It's allowed us to not overrun our hospital with patients who could otherwise be at home, who are either Covid-positive or unknown. That's allowed us to not exceed our capacity at our hospital despite large increases in volumes that we've seen overall coming through our ED.

We have had to cancel elective surgeries, as most of the hospitals in our area have also done, but our overall hospital census so far has been manageable. The other success story, at least in our facility, has been that despite having large volumes of patients come in --- with oftentimes over 100 patients in the hospital who are Covid-positive or persons under investigation --- we've not had any transmission of Covid to any of our health care workers. That's in large part \[due\] to cohorting these patients and maintaining nursing and provider expertise in PPE technique, which doesn't appear to have been broken resulting in hospital transmission amongst caregivers.

Mohta:

Dr. Diaz, thank you so much for speaking with NEJM Catalyst today.

Diaz:

Thank you very much.
